SOMANZ Research Grants
CALL FOR 2016 SOMANZ RESEARCH GRANT APPLICATIONS
The SOMANZ Research Grant is designed to encourage research in the field of Obstetric Medicine. It is funded directly by the Society and a single award of $10,000 is intended to be offered every second year to members of the Society.
The grant is designed to fund either clinical or basic science research projects in the field of Obstetric Medicine, including pilot studies. Ideally the project should be completed within the 12 months following receipt of the award. Successful applicants should aim to present their research findings at an annual SOMANZ meeting within 1-2 years of receiving the award.
Applications will be judged by the SOMANZ Council according to the following three criteria:
- Applicants must be a financial member of SOMANZ at the time of application
- Significance / Relevance of the Research to Obstetric Medicine
- Scientific Merit
- Track Record / Potential of the applicant
Applicants must complete the online application form and submit to the SOMANZ secretariat:
Ms Suzie Neylon
Executive Officer, SOMANZ
145 Macquarie St
Sydney NSW 2000
The file should be saved in MS Word and named with your Surname and First initial and then posted or emailed to SOMANZ as per the contact details above.
Applications close on Monday 31 October 2016.
*The SOMANZ Council reserve the right not to offer a grant if a suitable application is not received.
2014 SOMANZ Research Grant Recipient; Dr Katie Powell Kolling Institute of Medical Research, NSW
"Investigating the β-Isoform of the Thromboxane A2 Receptor (TPβ) and its potential use as a predictive biomarker in Pre-eclampsia”
At present there is no diagnostic test to predict whether pregnant women will develop pre-eclampsia at some stage throughout their pregnancy. We have recently discovered a significant, human specific factor that may explain the origins of pre-eclampsia. This companion study seeks to determine the diagnostic value in assessing expression of this factor, TRβ, in early pregnancy for the purpose of detecting women at risk of developing pre-eclampsia. We will compare the levels of TRb transcripts in third trimester serum from women with normal pregnancies and those with clinically diagnosed pre-eclampsia. Subsequently, we will assess TRβ transcript expression in first trimester serum from pregnancies of known outcome to determine whether monitoring TRβ early in pregnancy improves the sensitivity and/or accuracy of predictive algorithms used to assess risk of pre-eclampsia in pregnant populations.
2012 SOMANZ Research Grant Recipient; Dr Antonia Shand
“Inflammatory bowel disease: prevalence, trends and pregnancy outcomes in New South Wales”.